← Back
Data updated: Mar 10, 2026
ARTHUR GRP
Cardiovascular
ARTHUR GRP is a generic drug manufacturer focused on Cardiovascular.
2018
Since
5
Drugs
-
Trials
17
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
SEVELAMER CARBONATE 2025-10-27
SEVELAMER CARBONATE 2025-04-24
Labeling
RANOLAZINE 2025-04-15
SEVELAMER CARBONATE 2025-03-10
Labeling
SEVELAMER CARBONATE 2025-02-27
RANOLAZINE 2025-02-04
MELPHALAN HYDROCHLORIDE 2024-10-29
SEVELAMER CARBONATE 2024-10-24
BUSULFAN 2024-09-11
BUSULFAN 2024-07-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (4)
Company Info
- First Approval
- 2018-03-20
- Latest
- 2022-04-25
- Applications
- 5